{"id":863084,"date":"2025-06-24T08:28:47","date_gmt":"2025-06-24T12:28:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/"},"modified":"2025-06-24T08:28:47","modified_gmt":"2025-06-24T12:28:47","slug":"semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/","title":{"rendered":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">CAMPBELL, Calif.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">June 24, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt <span>Bitcoin<\/span> as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise\u00a0its\u00a0future healthcare business activities focused on early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring. CardioVanta will be structured\u00a0as\u00a0a high-margin,\u00a0software-as-a-service\u00a0(SAAS)\u00a0business model.\u00a0 It will seek capital from outside investors to validate its long-term value and fund its\u00a0relatively modest\u00a0initial capital needs.\u00a0 The markets for early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring\u00a0are estimated\u00a0in the multibillion-dollar range\u00a0and are projected to grow substantially due to rising cardiovascular disease, technology advancements such as artificial intelligence,\u00a0the aging population, and increasing adoption of wearable and\u00a0remote monitoring solutions.\u00a0 According to the Centers for Disease Control and Prevention, heart failure affects more than six million Americans and costs the U.S. healthcare system more than <span class=\"xn-money\">$30 billion<\/span> annually.\u00a0 While CardioVanta will focus on cardiac technology and care systems, Semler Scientific will continue marketing its QuantoFlo\u00ae device and software for early detection of peripheral artery disease. \u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg\" title=\"(PRNewsfoto\/Semler Scientific, Inc.)\" alt=\"(PRNewsfoto\/Semler Scientific, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;This exciting strategic plan aims to enhance our ability to combat chronic diseases, save more lives, and increase our <span>Bitcoin<\/span> holdings,&#8221; said\u00a0Eric Semler, chairman of Semler Scientific. &#8220;It represents a major opportunity for us to drive stockholder value and establish\u00a0Semler Scientific\u00a0as a dual-pronged powerhouse in the <span>Bitcoin<\/span> and medical\u00a0technology\u00a0sectors.&#8221;\u00a0<\/p>\n<p>&#8220;This announcement today advances our long-term mission to empower individuals with both monetary freedom and cutting-edge healthcare solutions that improve access to early, preventative care,&#8221; added <span class=\"xn-person\">Doug Murphy-Chutorian<\/span>, chief executive officer of Semler Scientific. &#8220;We view <span>Bitcoin<\/span> not merely as a treasury asset, but as a representation of the same core principles that drive our medical mission: sustainability, transparency, and autonomy.&#8221;<\/p>\n<p>\n        <b>About Semler Scientific,\u00a0Inc.:<\/b>\n      <\/p>\n<p>Semler Scientific, Inc. is the\u00a0second U.S. public company to adopt <span>Bitcoin<\/span> as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases.\u00a0 By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate <span>Bitcoin<\/span>. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific&#8217;s flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.\u00a0Additional information about Semler Scientific can be found at <a href=\"http:\/\/www.semlerscientific.com\" rel=\"nofollow\">www.semlerscientific.com<\/a>.<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release contains &#8220;forward-looking&#8221; statements. Such statements can be identified by, among other things, the use of forward-looking language such as the words &#8220;believe,&#8221; &#8220;goal,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;would,&#8221; &#8220;could&#8221; or words with similar meaning or the negatives of these terms or by the discussion of strategy or intentions. The forward-looking statements in this release include express or implied statements regarding CardioVanta&#8217;s future business activities and value; obtaining investment in CardioVanta and its capital needs; acquiring and holding <span>Bitcoin<\/span>; sales of securities under equity offerings and other financings to support additional <span>Bitcoin<\/span> purchases; and its cash flows from operations, among others. Such forward-looking statements are subject to a number of risks and uncertainties that could cause Semler Scientific&#8217;s actual results to differ materially from those discussed here, such as risks inherent with obtaining FDA clearance for additional indications; conducting certain healthcare operations through CardioVanta and bringing in new investors; investing in <span>Bitcoin<\/span>, including <span>Bitcoin<\/span>&#8216;s volatility; risk of implementing a <span>Bitcoin<\/span> treasury strategy; risks related to raising capital and generating sufficient cash to acquire <span>Bitcoin<\/span>; risks related to Semler Scientific&#8217;s indebtedness, and risks related to Semler Scientific&#8217;s proposed settlement with the Department of Justice; along with those other risk factors detailed in Semler Scientific&#8217;s filings with the Securities and Exchange Commission. These forward-looking statements involve assumptions, estimates, and uncertainties that reflect current internal projections, expectations or beliefs. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. All forward-looking statements contained in this press release are qualified in their entirety by these cautionary statements and the risk factors described above. Furthermore, all such statements are made as of the date of this press release and Semler Scientific assumes no obligation to update or revise these statements unless otherwise required by law.<\/p>\n<p>\n        <b>No Offer or Solicitation<\/b>\n      <\/p>\n<p>This press release does not and shall not constitute an offer to sell or a solicitation of an offer to buy any securities of Semler Scientific, Inc. or CardioVanta, Inc., nor shall there be any offer, solicitation or sale of such securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/p>\n<p>\n        <b>INVESTOR<\/b><br \/>\n        <b>CONTACT:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Renae Cormier<\/span><br \/>\n        <br \/>Chief Financial Officer<br \/><a href=\"mailto:ir@semlerscientific.com\" rel=\"nofollow\">ir@semlerscientific.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY16745&amp;sd=2025-06-24\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities-302488906.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities-302488906.html<\/a><\/p>\n<p>SOURCE  Semler Scientific, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY16745&amp;Transmission_Id=202506240800PR_NEWS_USPR_____NY16745&amp;DateId=20250624\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CAMPBELL, Calif. , June 24, 2025 \/PRNewswire\/ &#8212; Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise\u00a0its\u00a0future healthcare business activities focused on early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring. CardioVanta will be structured\u00a0as\u00a0a high-margin,\u00a0software-as-a-service\u00a0(SAAS)\u00a0business model.\u00a0 It will seek capital from outside investors to validate its long-term value and fund its\u00a0relatively modest\u00a0initial capital needs.\u00a0 The markets for early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring\u00a0are estimated\u00a0in the multibillion-dollar range\u00a0and are projected to grow substantially due to rising cardiovascular disease, technology advancements such as artificial intelligence,\u00a0the aging population, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-863084","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CAMPBELL, Calif. , June 24, 2025 \/PRNewswire\/ &#8212; Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise\u00a0its\u00a0future healthcare business activities focused on early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring. CardioVanta will be structured\u00a0as\u00a0a high-margin,\u00a0software-as-a-service\u00a0(SAAS)\u00a0business model.\u00a0 It will seek capital from outside investors to validate its long-term value and fund its\u00a0relatively modest\u00a0initial capital needs.\u00a0 The markets for early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring\u00a0are estimated\u00a0in the multibillion-dollar range\u00a0and are projected to grow substantially due to rising cardiovascular disease, technology advancements such as artificial intelligence,\u00a0the aging population, &hellip; Continue reading &quot;Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-24T12:28:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities\",\"datePublished\":\"2025-06-24T12:28:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/\"},\"wordCount\":892,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2394289\\\/Semler_Logo_registered.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/\",\"name\":\"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2394289\\\/Semler_Logo_registered.jpg\",\"datePublished\":\"2025-06-24T12:28:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2394289\\\/Semler_Logo_registered.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2394289\\\/Semler_Logo_registered.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/","og_locale":"en_US","og_type":"article","og_title":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk","og_description":"PR Newswire CAMPBELL, Calif. , June 24, 2025 \/PRNewswire\/ &#8212; Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise\u00a0its\u00a0future healthcare business activities focused on early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring. CardioVanta will be structured\u00a0as\u00a0a high-margin,\u00a0software-as-a-service\u00a0(SAAS)\u00a0business model.\u00a0 It will seek capital from outside investors to validate its long-term value and fund its\u00a0relatively modest\u00a0initial capital needs.\u00a0 The markets for early detection of heart\u00a0failure\u00a0and cardiac arrythmia\u00a0monitoring\u00a0are estimated\u00a0in the multibillion-dollar range\u00a0and are projected to grow substantially due to rising cardiovascular disease, technology advancements such as artificial intelligence,\u00a0the aging population, &hellip; Continue reading \"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-24T12:28:47+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities","datePublished":"2025-06-24T12:28:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/"},"wordCount":892,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/","name":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg","datePublished":"2025-06-24T12:28:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2394289\/Semler_Logo_registered.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/semler-scientific-announces-cardiovanta-a-new-entity-that-seeks-to-unlock-value-of-future-medical-business-opportunities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Semler Scientific\u00ae Announces CardioVanta\u2122, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=863084"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863084\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=863084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=863084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=863084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}